Effect of intrathecal different dose of kinesin superfamily 17 on the development of bone cancer pain in mice
Ming Liu,Yue Liu,Bailing Hou,Dan Bu,Linyu Shi,Xiaoping Gu,Zhengliang Ma
DOI: https://doi.org/10.3760/cma.j.issn.1673-4378.2015.03.001
2015-01-01
Abstract:Objective To investigate the effect of different doses of kinesin superfamily protein 17 (KIF17) antisense oligodeoxy nucleotide on a mouse model of bone cancer pain.Methods Fifty-five C3H/HeJ mice,4-6 weeks of age,weighting 20 g～25 g,were randomly divided into two groups:bone cancer pain group (group A,n=41) and sham operation group (group S,n=14).Group A was induced by implantation of 20 μl α-minimal essence medium (α-MEM) which containing 2×105 osteosarcoma (NCTC 2472) cells into the intramedullary space of the right femur.And 20 μl α-MEM with no cancer cell was injected instead to group S.The number of spontaneous flinches (NSF) and the paw withdrawal mechanical threshold (PWMT) were measured at the day before inoculation (base) and the day 4,7,10 and 14 after inoculation.According to the corresponding time points,ten mice were sacrificed,and the lumbar segment of spinal cord(L3-5) was removed for determination the expression of KIF17 using Western blot.At the day 14 after inoculation,the mice of group A were randomly divided into four groups,KIF17 antisense oligodeoxy nucleotide 2.5,5.0,10.0 μg group (group A1-group A3) and the control group (group Ac).Each group had nine mice.group A1-group A3 were treated by intrathecal injection the corresponding dose of KIF17 antisense oligodeoxy nucleotide group S and group AC was treated by saline.The volume of all drugs was 5 μl.The pain behaviors were measured at 2,12,24,36 h and 48 h after administration and determinated the expression of KIF17.Results Compared with group S [(2.15±0.49),(1.80±0.39) g] and the base[(2.08±0.34),(1.88±0.35) g],the NSF[(11.95±0.78)] was significantly increased and PWMT[(0.34±0.11) g] was decreased at 14 d after inoculation in the bone caner pain groups(P＜0.05),the expression of KIF17 were increased,compared with group AC,the NSF [2 h (4.80±0.40)] was decreased and the PWMT [2 h (0.95±0.33) g] was increased at 2,12,24 h after administration in group A1 (P＜0.05),and the NSF[2 h(2.35±0.26),(2.53±0.21)] was decreased and the PWMT[2 h(1.70±0.32),(1.73±0.40) g] was increased at 2,12,24,36 h after administration in group A2-group A3,group A2 compared with group A3,the NSF and PWMT were no statistically significant difference (P＞0.05),after intrathecal administration,the expression of KIF17 was reduced in group A1-group A3 (P＜0.05).Conclusions Intrathecal KIF17 antisense oligodeoxy nucleotide in the mice of bone cancer pain improve the pain behaviors,and the analgesic effect is time-and dose-related.